Cosmo Pharmaceuticals N.V.
CMOPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $153 | $2 | $24 | $24 |
| Dep. & Amort. | $12 | $14 | $14 | $7 |
| Deferred Tax | $0 | $0 | $0 | -$21 |
| Stock-Based Comp. | $2 | $4 | $2 | $1 |
| Change in WC | $0 | $1 | -$13 | -$5 |
| Other Non-Cash | -$5 | $2 | $6 | $6 |
| Operating Cash Flow | $162 | $23 | $33 | $13 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$3 | -$7 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $23 |
| Inv. Purchases | -$157 | -$61 | -$54 | -$1 |
| Inv. Sales/Matur. | $34 | $118 | $36 | $8 |
| Other Inv. Act. | -$1 | -$11 | $27 | $3 |
| Investing Cash Flow | -$129 | $42 | $2 | $25 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$176 | -$1 | -$3 |
| Stock Issued | $3 | $1 | $0 | $1 |
| Stock Repurch. | -$6 | -$12 | -$25 | -$21 |
| Dividends Paid | -$32 | -$17 | -$16 | $0 |
| Other Fin. Act. | -$5 | -$7 | -$5 | -$5 |
| Financing Cash Flow | -$40 | -$211 | -$46 | -$27 |
| Forex Effect | $1 | -$0 | -$2 | $2 |
| Net Chg. in Cash | -$6 | -$136 | -$13 | $13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $50 | $186 | $199 | $186 |
| End Cash | $44 | $50 | $186 | $199 |
| Free Cash Flow | $157 | $18 | $26 | $4 |